Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners
Abstract
To implement and evaluate pharmaceutical care services for patients with hyperlipidemias in the community pharmacy setting, to evaluate the results of a pharmaceutical care training process for pharmacists by using an assessment quiz, and to measure patient outcomes resulting from provision of pharmaceutical care to patients with hyperlipidemia. A prospective study was conducted over a 1-year period. Patients served as their own controls. Two independent community pharmacies in Richmond, Virginia. Twenty-five adult patients with confirmed dyslipidemias completed the study. Study pharmacists assessed each patient and assisted in setting therapeutic goals; patients also completed a visit with a registered dietitian. Drug therapy recommendations were made to physicians by the pharmacist when appropriate. Follow-up was scheduled with the pharmacist to ensure positive outcomes and reduce adverse effects. Fasting lipoprotein profiles were measured initially and at 6 and 12 months. The SF-36 survey, the MacKeigan-Larson satisfaction survey, and a patient opinion survey were administered initially and at the conclusion of the study. Total cholesterol and low-density lipoprotein cholesterol values were significantly decreased at 12 mont...Continue Reading
References
Pharmacist-managed, physician-directed asthma management program reduces emergency department visits
Citations
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
Related Concepts
Related Feeds
ApoE, Lipids & Cholesterol
Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.